{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:13:36Z","timestamp":1788984816181,"version":"build-2803163510"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s13555-026-01856-1","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T18:21:32Z","timestamp":1784139692000},"page":"4459-4473","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chronic Spontaneous Urticaria (CSU) in Chinese Patients: Real-World Evidence of Disease Control and Treatment Patterns from the Urticaria Voices Study"],"prefix":"10.1007","volume":"16","author":[{"given":"Zuotao","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Raftery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Chapman-Rothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallavi","family":"Saraswat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravneet Kaur","family":"Kohli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Constantinescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojiao","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7155-6079","authenticated-orcid":false,"given":"Bin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"issue":"11","key":"1856_CR1","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1097\/CM9.0000000000002172","volume":"135","author":"J Li","year":"2022","unstructured":"Li J, Mao D, Liu S, et al. Epidemiology of urticaria in China: a population-based study. Chin Med J (Engl). 2022;135(11):1369\u201375.","journal-title":"Chin Med J (Engl)"},{"key":"1856_CR2","doi-asserted-by":"publisher","DOI":"10.2196\/50114","volume":"9","author":"X Liu","year":"2023","unstructured":"Liu X, Cao Y, Wang W. Burden of and trends in urticaria globally, regionally, and nationally from 1990 to 2019: systematic analysis. JMIR Public Health Surveill. 2023;9:e50114.","journal-title":"JMIR Public Health Surveill"},{"issue":"12","key":"1856_CR3","first-page":"1123","volume":"55","author":"J Xu","year":"2022","unstructured":"Centre for Urticaria Research, Chinese Society of Dermatology, Xu J. Guidelines for diagnosis and treatment of urticaria in China. Chin J Dermatol. 2022;55(12):1123\u201338.","journal-title":"Chin J Dermatol."},{"key":"1856_CR4","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/all.15090","volume":"77","author":"T Zuberbier","year":"2022","unstructured":"Zuberbier T, Abdul Latiff AH, Abuzakouk M, et al. The international EAACI\/GA2LEN\/EuroGuiDerm\/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2022;77:734\u201366.","journal-title":"Allergy"},{"key":"1856_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/all.70210","volume":"81","author":"T Zuberbier","year":"2026","unstructured":"Zuberbier T, Ansari AH, Abdul Latiff AH, et al. The international guideline for the definition, classification, diagnosis and management of urticaria. Allergy. 2026;81:1\u201351.","journal-title":"Allergy"},{"issue":"11","key":"1856_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2021.100610","volume":"14","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Cai T, Chen H, et al. Expert consensus on the use of omalizumab in chronic urticaria in China. World Allergy Organ J. 2021;14(11):100610.","journal-title":"World Allergy Organ J"},{"key":"1856_CR7","unstructured":"National Reimbursement Drug List for National Basic Medical Insurance, Maternity Insurance and Work Injury Insurance (NRDL). Beijing: National Healthcare Security Administration; 2026."},{"key":"1856_CR8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.vhri.2021.12.003","volume":"30","author":"GG Liu","year":"2022","unstructured":"Liu GG, Wu J, He X, Jiang Y. Policy updates on access to and affordability of innovative medicines in China. Value Health Reg Issues. 2022;30:59\u201366.","journal-title":"Value Health Reg Issues"},{"key":"1856_CR9","doi-asserted-by":"publisher","first-page":"1591358","DOI":"10.3389\/fpubh.2025.1591358","volume":"13","author":"H Gong","year":"2025","unstructured":"Gong H, Wu W, Li J, et al. China\u2019s coordinated tripartite medical reform: strategic balancing of interests among pharmaceuticals, healthcare, and health insurance. Front Public Health. 2025;13:1591358.","journal-title":"Front Public Health"},{"issue":"12","key":"1856_CR10","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.ijsu.2014.07.014","volume":"12","author":"JP Vandenbroucke","year":"2014","unstructured":"Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Int J Surg. 2014;12(12):1500\u201324.","journal-title":"Int J Surg"},{"issue":"5","key":"1856_CR11","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.jaci.2013.12.1076","volume":"133","author":"K Weller","year":"2014","unstructured":"Weller K, Groffik A, Church MK, et al. Development and validation of the Urticaria Control Test: a patient-reported outcome instrument for assessing urticaria control. J Allergy Clin Immunol. 2014;133(5):1365\u201372.","journal-title":"J Allergy Clin Immunol"},{"key":"1856_CR12","volume-title":"ECDEU assessment manual for psychopharmacology","year":"1976","unstructured":"Guy W, editor. ECDEU assessment manual for psychopharmacology. Rockville: US Department of Health, Education, and Welfare Public Health Service Alcohol, Drug Abuse, and Mental Health Administration; 1976."},{"issue":"1","key":"1856_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/jdv.70027","volume":"40","author":"E Kocat\u00fcrk","year":"2026","unstructured":"Kocat\u00fcrk E, Salameh P, Asero R, et al. Sex matters in CSU: women face greater burden and poorer urticaria control, especially in midlife-CURE insights. J Eur Acad Dermatol Venereol. 2026;40(1):67\u201378.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"1856_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14041162","volume":"14","author":"M Hide","year":"2025","unstructured":"Hide M, Uda A, Maki F, et al. Prevalence and burden of chronic spontaneous urticaria in Japan: a cross-sectional study. J Clin Med. 2025;14(4):1162.","journal-title":"J Clin Med"},{"issue":"11","key":"1856_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2024.100974","volume":"17","author":"S Preis","year":"2024","unstructured":"Preis S, Claussen C, Ziehfreund S, et al. Is there a difference between women and men in chronic spontaneous urticaria? A systematic review on gender and sex differences in CSU patients. World Allergy Organ J. 2024;17(11):100974.","journal-title":"World Allergy Organ J"},{"issue":"4","key":"1856_CR16","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1017\/S1478951522000360","volume":"21","author":"X Xu","year":"2023","unstructured":"Xu X, Luckett T, Lovell M, Phillips JL. Cultural factors affecting Chinese migrants\u2019 perceptions and responses to cancer pain and its pharmacological management: a convergent mixed-method study. Palliat Support Care. 2023;21(4):688\u201396.","journal-title":"Palliat Support Care"},{"key":"1856_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/all.70199","volume":"81","author":"P Kolkhir","year":"2026","unstructured":"Kolkhir P, Salameh P, Zajac M, et al. Unmet needs in treatment escalation for chronic spontaneous urticaria: findings from the CURE registry. Allergy. 2026;81:1\u201311.","journal-title":"Allergy"},{"issue":"12 Suppl 1","key":"1856_CR18","first-page":"S598","volume":"28","author":"S Joshi","year":"2025","unstructured":"Joshi S, Song Z, Chen Q, et al. Treatment preferences in adults with chronic spontaneous urticaria symptomatic on H1-antihistamines: insights from CHOICE-CSU 2 study. Value Health. 2025;28(12 Suppl 1):S598.","journal-title":"Value Health"},{"issue":"1","key":"1856_CR19","first-page":"12","volume":"41","author":"P Weerasubpong","year":"2023","unstructured":"Weerasubpong P, Jiamton S, Phumariyapong P, et al. Prevalence of concomitant angioedema in chronic spontaneous urticaria: a systematic review and meta-analysis. Asian Pac J Allergy Immunol. 2023;41(1):12\u20139.","journal-title":"Asian Pac J Allergy Immunol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01856-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-026-01856-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01856-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:21:22Z","timestamp":1788981682000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-026-01856-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1856"],"URL":"https:\/\/doi.org\/10.1007\/s13555-026-01856-1","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"28 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Zuotao Zhao, Yi Li and Bin Yang have no COIs to disclose. Tara Raftery is an employee of Novartis Ireland Ltd, Dublin, Ireland, and reports holding shares of Novartis Pharma AG, Basel, Switzerland. Nadine Chapman-Rothe is an employee of Novartis Pharma AG, Basel, Switzerland, and reports holding shares of Novartis Pharma AG. Pallavi Saraswat is an employee of Novartis Healthcare Pvt Ltd, Hyderabad, India, and reports holding shares of Novartis Pharma AG, Basel, Switzerland. Jessica McCarthy is an employee of Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, and reports holding shares of Novartis Pharma AG, Basel, Switzerland. Ravneet Kohli is an employee of Novartis Healthcare Pvt Ltd, Hyderabad, India. Cristina Constantinescu is an employee of Ipsos, a consulting company that received funding from Novartis for the design and execution of this study. Angie Li is an employee of Ipsos China, a consulting company that received funding from Novartis for communication of study affairs in China. Guojiao You is an employee of Beijing Novartis Pharma Co., Ltd, Shanghai, China, and reports holding shares of Novartis Pharma AG, Basel, Switzerland. Ruixin Tan is an employee of Beijing Novartis Pharma Co., Ltd, Shanghai, China, and reports holding shares of Novartis Pharma AG, Basel, Switzerland.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was designed, implemented and reported in accordance with the Guidelines for Good Pharmacoepidemiology Practices (GPP) of the International Society for Pharmacoepidemiology (ISPE 2015), the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guidelines (Vandenbroucke et al. 2014) [\n                      \n                      ], and with the ethical principles laid down in the Declaration of Helsinki of 1964 and its later amendments. Study materials (protocol, questionnaire, informed consent form) were reviewed and approved by the Tsinghua University Science and Technology Ethics Committee (Protocol: CLOU064A2008; Institutional Review Board [IRB] ID: THU-01-2025-1009-R1). Moreover, the study was also reviewed and granted exemption by Pearl IRB (Protocol: CLOU064A2008; IRB ID: 2025-0469). All participants had to review and electronically confirm their agreement with the informed consent form prior to being able to participate in the study. No personal identifiers were recorded, and all results are reported in an aggregate form.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}